Skip to main content
PMC home page
Protein & Cell logoLink to Protein & Cell
. 2013 Sep 20;4(10):747–760. doi: 10.1007/s13238-013-3073-2

GPCR activation: protonation and membrane potential

Xuejun C Zhang 1,✉, Kening Sun 1, Laixing Zhang 1, Xuemei Li 1, Can Cao 1
PMCID: PMC4875432  PMID: 24057762

Abstract

GPCR proteins represent the largest family of signaling membrane proteins in eukaryotic cells. Their importance to basic cell biology, human diseases, and pharmaceutical interventions is well established. Many crystal structures of GPCR proteins have been reported in both active and inactive conformations. These data indicate that agonist binding alone is not sufficient to trigger the conformational change of GPCRs necessary for binding of downstream G-proteins, yet other essential factors remain elusive. Based on analysis of available GPCR crystal structures, we identified a potential conformational switch around the conserved Asp2.50, which consistently shows distinct conformations between inactive and active states. Combining the structural information with the current literature, we propose an energy-coupling mechanism, in which the interaction between a charge change of the GPCR protein and the membrane potential of the living cell plays a key role for GPCR activation.

Keywords: GPCR, membrane potential, protonation, activation

References

  1. Angel TE, Chance MR, Palczewski K. Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors. Proc Natl Acad Sci U S A. 2009;106:8555–8560. doi: 10.1073/pnas.0903545106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ballesteros JA, Jensen AD, Liapakis G, Rasmussen SG, Shi L, Gether U, Javitch JA. Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem. 2001;276:29171–29177. doi: 10.1074/jbc.M103747200. [DOI] [PubMed] [Google Scholar]
  3. Ballesteros JA, Weinstein H. Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 1995;25:366–428. [Google Scholar]
  4. Ben-Chaim Y, Chanda B, Dascal N, Bezanilla F, Parnas I, Parnas H. Movement of ‘gating charge’ is coupled to ligand binding in a G-protein-coupled receptor. Nature. 2006;444:106–109. doi: 10.1038/nature05259. [DOI] [PubMed] [Google Scholar]
  5. Bihoreau C, Monnot C, Davies E, Teutsch B, Bernstein KE, Corvol P, Clauser E. Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. Proc Natl Acad Sci U S A. 1993;90:5133–5137. doi: 10.1073/pnas.90.11.5133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ceresa BP, Limbird LE. Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in nonreciprocal disruption of alpha 2-adrenergic receptor-G-protein interactions. A negative charge at amino acid residue 79 forecasts alpha 2A-adrenergic receptor sensitivity to allosteric modulation by monovalent cations and fully effective receptor/G-protein coupling. J Biol Chem. 1994;269:29557–29564. [PubMed] [Google Scholar]
  7. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science. 2007;318:1258–1265. doi: 10.1126/science.1150577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chien EY, Liu W, Zhao Q, Katritch V, Han GW, Hanson MA, Shi L, Newman AH, Javitch JA, Cherezov V, et al. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science. 2010;330:1091–1095. doi: 10.1126/science.1197410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Choe HW, Kim YJ, Park JH, Morizumi T, Pai EF, Krauss N, Hofmann KP, Scheerer P, Ernst OP. Crystal structure of metarhodopsin II. Nature. 2011;471:651–655. doi: 10.1038/nature09789. [DOI] [PubMed] [Google Scholar]
  10. Conn PM, Ulloa-Aguirre A, Ito J, Janovick JA. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo. Pharmacol Rev. 2007;59:225–250. doi: 10.1124/pr.59.3.2. [DOI] [PubMed] [Google Scholar]
  11. Daiyasu H, Nemoto W, Toh H. Evolutionary Analysis of Functional Divergence among Chemokine Receptors, Decoy Receptors, and Viral Receptors. Front Micr obiol. 2012;3:264. doi: 10.3389/fmicb.2012.00264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DeCoursey TE. Voltage-gated proton channels and other proton transfer pathways. Physiol Rev. 2003;83:475–579. doi: 10.1152/physrev.00028.2002. [DOI] [PubMed] [Google Scholar]
  13. Dessen A, Tang J, Schmidt H, Stahl M, Clark JD, Seehra J, Somers WS. Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism. Cell. 1999;97:349–360. doi: 10.1016/s0092-8674(00)80744-8. [DOI] [PubMed] [Google Scholar]
  14. Eyring G, Mathies R. Resonance Raman studies of bathorhodopsin: evidence for a protonated Schiff base linkage. Proc Natl Acad Sci U S A. 1979;76:33–37. doi: 10.1073/pnas.76.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fahmy K, Jager F, Beck M, Zvyaga TA, Sakmar TP, Siebert F. Protonation states of membrane-embedded carboxylic acid groups in rhodopsin and metarhodopsin II: a Fourier-transform infrared spectroscopy study of site-directed mutants. Proc Natl Acad Sci U S A. 1993;90:10206–10210. doi: 10.1073/pnas.90.21.10206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gasperi V, Dainese E, Oddi S, Sabatucci A, Maccarrone M. GPR55 and its interaction with membrane lipids: comparison with other endocannabinoid-binding receptors. Curr Med Chem. 2013;20:64–78. [PubMed] [Google Scholar]
  17. Ghanouni P, Schambye H, Seifert R, Lee TW, Rasmussen SG, Gether U, Kobilka BK. The effect of pH on beta(2) adrenoceptor function. Evidence for protonation-dependent activation. J Biol Chem. 2000;275:3121–3127. doi: 10.1074/jbc.275.5.3121. [DOI] [PubMed] [Google Scholar]
  18. Granier S, Manglik A, Kruse AC, Kobilka TS, Thian FS, Weis WI, Kobilka BK. Structure of the delta-opioid receptor bound to naltrindole. Nature. 2012;485:400–404. doi: 10.1038/nature11111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gripentrog JM, Jesaitis AJ, Miettinen HM. A single amino acid substitution (N297A) in the conserved NPXXY sequence of the human N-formyl peptide receptor results in inhibition of desensitization and endocytosis, and a dose-dependent shift in p42/44 mitogen-activated protein kinase activation and chemotaxis. Biochem J. 2000;352:399–407. [PMC free article] [PubMed] [Google Scholar]
  20. Haga K, Kruse AC, Asada H, Yurugi-Kobayashi T, Shiroishi M, Zhang C, Weis WI, Okada T, Kobilka BK, Haga T, et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature. 2012;482:547–551. doi: 10.1038/nature10753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola VP, Chien EY, Velasquez J, Kuhn P, Stevens RC. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure. 2008;16:897–905. doi: 10.1016/j.str.2008.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hanson MA, Roth CB, Jo E, Griffith MT, Scott FL, Reinhart G, Desale H, Clemons B, Cahalan SM, Schuerer SC, et al. Crystal structure of a lipid G protein-coupled receptor. Science. 2012;335:851–855. doi: 10.1126/science.1215904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Healy DP. Genetic analysis of G protein-coupled receptor genes. Methods Enzymol. 2002;343:448–459. doi: 10.1016/s0076-6879(02)43151-5. [DOI] [PubMed] [Google Scholar]
  24. Hulme EC. GPCR activation: a mutagenic spotlight on crystal structures. Trends Pharmacol Sci. 2013;34:67–84. doi: 10.1016/j.tips.2012.11.002. [DOI] [PubMed] [Google Scholar]
  25. Illergard K, Kauko A, Elofsson A. Why are polar residues within the membrane core evolutionary conserved? Proteins. 2011;79:79–91. doi: 10.1002/prot.22859. [DOI] [PubMed] [Google Scholar]
  26. Im DS. Two ligands for a GPCR, proton vs lysolipid. Acta pharmacologica Sinica. 2005;26:1435–1441. doi: 10.1111/j.1745-7254.2005.00237.x. [DOI] [PubMed] [Google Scholar]
  27. Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, Lane JR, Ijzerman AP, Stevens RC. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science. 2008;322:1211–1217. doi: 10.1126/science.1164772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Jiang D, Zhao Y, Wang X, Fan J, Heng J, Liu X, Feng W, Kang X, Huang B, Liu J, et al. Structure of the YajR transporter suggests a transport mechanism based on the conserved motif A. Proc Natl Acad Sci U S A. 2013;110:14664–14669. doi: 10.1073/pnas.1308127110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao WJ, Johnson M, Gunwaldsen C, Huang LY, et al. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature. 1998;396:674–679. doi: 10.1038/25348. [DOI] [PubMed] [Google Scholar]
  30. Katritch V, Cherezov V, Stevens RC. Structure-function of the G protein-coupled receptor superfamily. Annu Rev Pharmacol Toxicol. 2013;53:531–556. doi: 10.1146/annurev-pharmtox-032112-135923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Krishnakumar SS, London E. The control of transmembrane helix transverse position in membranes by hydrophilic residues. J Mol Biol. 2007;374:1251–1269. doi: 10.1016/j.jmb.2007.10.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kruse AC, Hu J, Pan AC, Arlow DH, Rosenbaum DM, Rose-mond E, Green HF, Liu T, Chae PS, Dror RO, et al. Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature. 2012;482:552–556. doi: 10.1038/nature10867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lebon G, Warne T, Edwards PC, Bennett K, Langmead CJ, Leslie AG, Tate CG. Agonist-bound adenosine A(2A) receptor structures reveal common features of GPCR activation. Nature. 2011;474:521–525. doi: 10.1038/nature10136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lebon G, Warne T, Tate CG. Agonist-bound structures of G protein-coupled receptors. Curr Opin Struct Biol. 2012;22:482–490. doi: 10.1016/j.sbi.2012.03.007. [DOI] [PubMed] [Google Scholar]
  35. Li B, Nowak NM, Kim SK, Jacobson KA, Bagheri A, Schmidt C, Wess J. Random mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast: identification of secondsite mutations that restore function to a coupling-deficient mutant M3 receptor. J Biol Chem. 2005;280:5664–5675. doi: 10.1074/jbc.M411623200. [DOI] [PubMed] [Google Scholar]
  36. Liu W, Chun E, Thompson AA, Chubukov P, Xu F, Katritch V, Han GW, Roth CB, Heitman LH, AP IJ, et al. Structural basis for allosteric regulation of GPCRs by sodium ions. Science. 2012;337:232–236. doi: 10.1126/science.1219218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Lohse MJ, Hoffmann C, Nikolaev VO, Vilardaga JP, Bunemann M. Kinetic analysis of G protein-coupled receptor signaling using fluorescence resonance energy transfer in living cells. Adv Protein Chem. 2007;74:167–188. doi: 10.1016/S0065-3233(07)74005-6. [DOI] [PubMed] [Google Scholar]
  38. Lohse MJ, Nikolaev VO, Hein P, Hoffmann C, Vilardaga JP, Bunemann M. Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors. Trends Pharmacol Sci. 2008;29:159–165. doi: 10.1016/j.tips.2007.12.002. [DOI] [PubMed] [Google Scholar]
  39. Madathil S, Fahmy K. Lipid protein interactions couple protonation to conformation in a conserved cytosolic domain of G protein-coupled receptors. J Biol Chem. 2009;284:28801–28809. doi: 10.1074/jbc.M109.002030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Mahalingam M, Martinez-Mayorga K, Brown MF, Vogel R. Two protonation switches control rhodopsin activation in membranes. Proc Natl Acad Sci U S A. 2008;105:17795–17800. doi: 10.1073/pnas.0804541105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Mahaut-Smith MP, Martinez-Pinna J, Gurung IS. A role for membrane potential in regulating GPCRs? Trends Pharmacol Sci. 2008;29:421–429. doi: 10.1016/j.tips.2008.05.007. [DOI] [PubMed] [Google Scholar]
  42. Manallack DT. The pK(a) distribution of drugs: application to drug discovery. Perspect Medicin Chem. 2008;1:25–38. [PMC free article] [PubMed] [Google Scholar]
  43. Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK, Granier S. Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature. 2012;485:321–326. doi: 10.1038/nature10954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Marie J, Maigret B, Joseph MP, Larguier R, Nouet S, Lombard C, Bonnafous JC. Tyr292 in the seventh transmembrane domain of the AT1A angiotensin II receptor is essential for its coupling to phospholipase C. J Biol Chem. 1994;269:20815–20818. [PubMed] [Google Scholar]
  45. Martin S, Botto JM, Vincent JP, Mazella J. Pivotal role of an aspartate residue in sodium sensitivity and coupling to G proteins of neurotensin receptors. Mol Pharmacol. 1999;55:210–215. doi: 10.1124/mol.55.2.210. [DOI] [PubMed] [Google Scholar]
  46. Matthews RG, Hubbard R, Brown PK, Wald G. Tautomeric Forms of Metarhodopsin. J Gen Physiol. 1963;47:215–240. doi: 10.1085/jgp.47.2.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Miura S, Kiya Y, Hanzawa H, Nakao N, Fujino M, Imaizumi S, Matsuo Y, Yanagisawa H, Koike H, Komuro I, et al. Small molecules with similar structures exhibit agonist, neutral antagonist or inverse agonist activity toward angiotensin II type 1 receptor. PLoS One. 2012;7:e37974. doi: 10.1371/journal.pone.0037974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Mixcoha E, Garcia-Viloca M, Lluch JM, Gonzalez-Lafont A. Theoretical analysis of the catalytic mechanism of helicobacter pylori glutam ate racemase. J Phys Chem B. 2012;116:12406–12414. doi: 10.1021/jp3054982. [DOI] [PubMed] [Google Scholar]
  49. Monnot C, Bihoreau C, Conchon S, Curnow KM, Corvol P, Clauser E. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J Biol Chem. 1996;271:1507–1513. doi: 10.1074/jbc.271.3.1507. [DOI] [PubMed] [Google Scholar]
  50. Montaner S, Kufareva I, Abagyan R, Gutkind JS. Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases. Annu Rev Pharmacol Toxicol. 2013;53:331–354. doi: 10.1146/annurev-pharmtox-010510-100608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Mouritsen OG, Bloom M. Mattress model of lipid-protein interactions in membranes. Biophys J. 1984;46:141–153. doi: 10.1016/S0006-3495(84)84007-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Murakami M, Kouyama T. Crystal structure of squid rhodopsin. Nature. 2008;453:363–367. doi: 10.1038/nature06925. [DOI] [PubMed] [Google Scholar]
  53. Nie B, Stutzman J, Xie A. A vibrational spectral maker for probing the hydrogen-bonding status of protonated Asp and Glu residues. Biophys J. 2005;88:2833–2847. doi: 10.1529/biophysj.104.047639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Niedernberg A, Tunaru S, Blaukat A, Ardati A, Kostenis E. Sphingosine 1-phosphate and dioleoylphosphatidic acid are low affinity agonists for the orphan receptor GPR63. Cell Signal. 2003;15:435–446. doi: 10.1016/s0898-6568(02)00119-5. [DOI] [PubMed] [Google Scholar]
  55. Nygaard R, Frimurer TM, Holst B, Rosenkilde MM, Schwartz TW. Ligand binding and micro-switches in 7TM receptor structures. Trends Pharmacol Sci. 2009;30:249–259. doi: 10.1016/j.tips.2009.02.006. [DOI] [PubMed] [Google Scholar]
  56. Onufriev A, Smondyrev A, Bashford D. Proton affinity changes driving unidirectional proton transport in the bacteriorhodopsin photocycle. J Mol Biol. 2003;332:1183–1193. doi: 10.1016/s0022-2836(03)00903-3. [DOI] [PubMed] [Google Scholar]
  57. Page MJ, Di Cera E. Role of Na+ and K+ in enzyme function. Physiol Rev. 2006;86:1049–1092. doi: 10.1152/physrev.00008.2006. [DOI] [PubMed] [Google Scholar]
  58. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science. 2000;289:739–745. doi: 10.1126/science.289.5480.739. [DOI] [PubMed] [Google Scholar]
  59. Parent JL, Le Gouill C, Rola-Pleszczynski M, Stankova J. Mutation of an aspartate at position 63 in the human platelet-activating factor receptor augments binding affinity but abolishes G-protein-coupling and inositol phosphate production. Biochem Biophys Res Commun. 1996;219:968–975. doi: 10.1006/bbrc.1996.0341. [DOI] [PubMed] [Google Scholar]
  60. Park JH, Scheerer P, Hofmann KP, Choe HW, Ernst OP. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature. 2008;454:183–187. doi: 10.1038/nature07063. [DOI] [PubMed] [Google Scholar]
  61. Parkes JH, Liebman PA. Temperature and pH dependence of the metarhodopsin I-metarhodopsin II kinetics and equilibria in bovine rod disk membrane suspensions. Biochemistry. 1984;23:5054–5061. doi: 10.1021/bi00316a035. [DOI] [PubMed] [Google Scholar]
  62. Periole X, Ceruso MA, Mehler EL. Acid-base equilibria in rhodopsin: dependence of the protonation state of glu134 on its environment. Biochemistry. 2004;43:6858–6864. doi: 10.1021/bi049949e. [DOI] [PubMed] [Google Scholar]
  63. Proulx CD, Holleran BJ, Boucard AA, Escher E, Guillemette G, Leduc R. Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptor. Mol Pharmacol. 2008;74:552–561. doi: 10.1124/mol.108.045054. [DOI] [PubMed] [Google Scholar]
  64. Radu CG, Nijagal A, McLaughlin J, Wang L, Witte ON. Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. Proc Natl Acad Sci U S A. 2005;102:1632–1637. doi: 10.1073/pnas.0409415102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Rasmussen SG, Choi HJ, Fung JJ, Pardon E, Casarosa P, Chae PS, Devree BT, Rosenbaum DM, Thian FS, Kobilka TS, et al. Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor. Nature. 2011;469:175–180. doi: 10.1038/nature09648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, Thian FS, Chae PS, Pardon E, Calinski D, et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature. 2011;477:549–555. doi: 10.1038/nature10361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Ratnala VR, Kiihne SR, Buda F, Leurs R, de Groot HJ, DeGrip WJ. Solid-state NMR evidence for a protonation switch in the binding pocket of the H1 receptor upon binding of the agonist histamine. J Am Chem Soc. 2007;129:867–872. doi: 10.1021/ja0652262. [DOI] [PubMed] [Google Scholar]
  68. Ringholm A, Klovins J, Rudzish R, Phillips S, Rees JL, Schioth HB. Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J Invest Dermatol. 2004;123:917–923. doi: 10.1111/j.0022-202X.2004.23444.x. [DOI] [PubMed] [Google Scholar]
  69. Rodriguez D, Pineiro A, Gutierrez-de-Teran H. Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors. Biochemistry. 2011;50:4194–4208. doi: 10.1021/bi200100t. [DOI] [PubMed] [Google Scholar]
  70. Rosenbaum DM, Zhang C, Lyons JA, Holl R, Aragao D, Arlow DH, Rasmussen SG, Choi HJ, Devree BT, Sunahara RK, et al. Structure and function of an irreversible agonistbeta(2) adrenoceptor complex. Nature. 2011;469:236–240. doi: 10.1038/nature09665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Roth CB, Hanson MA, Stevens RC. Stabilization of the human beta2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue in GPCR structure. J Mol Biol. 2008;376:1305–1319. doi: 10.1016/j.jmb.2007.12.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Scheer A, Fanelli F, Costa T, De Benedetti PG, Cotecchia S. Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J. 1996;15:3566–3578. [PMC free article] [PubMed] [Google Scholar]
  73. Scheerer P, Park JH, Hildebrand PW, Kim YJ, Krauss N, Choe HW, Hofmann KP, Ernst OP. Crystal structure of opsin in its G-protein-interacting conformation. Nature. 2008;455:497–502. doi: 10.1038/nature07330. [DOI] [PubMed] [Google Scholar]
  74. Schlinkmann KM, Honegger A, Tureci E, Robison KE, Lipovsek D, Pluckthun A. Critical features for biosynthesis, stability, and functionality of a G protein-coupled receptor uncovered by all-versus-all mutations. Proc Natl Acad Sci U S A. 2012;109:9810–9815. doi: 10.1073/pnas.1202107109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Selent J, Sanz F, Pastor M, De Fabritiis G. Induced effects of sodium ions on dopaminergic G-protein coupled receptors. PLoS Comput Biol. 2010;6:e1000884. doi: 10.1371/journal.pcbi.1000884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Shenker A. G protein-coupled receptor structure and function: the impact of disease-causing mutations. Baillieres Clin Endocrinol Meta b. 1995;9:427–451. doi: 10.1016/s0950-351x(95)80519-2. [DOI] [PubMed] [Google Scholar]
  77. Shimamura T, Hiraki K, Takahashi N, Hori T, Ago H, Masuda K, Takio K, Ishiguro M, Miyano M. Crystal structure of squid rhodopsin with intracellularly extended cytoplasmic region. J Biol Chem. 2008;283:17753–17756. doi: 10.1074/jbc.C800040200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Shimamura T, Shiroishi M, Weyand S, Tsujimoto H, Winter G, Katritch V, Abagyan R, Cherezov V, Liu W, Han GW, et al. Structure of the human histamine H1 receptor complex with doxepin. Nature. 2011;475:65–70. doi: 10.1038/nature10236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Smith NJ. Low affinity GPCRs for metabolic intermediates: challenges for pharmacologists. Front Endocrinol (La usanne) 2012;3:1. doi: 10.3389/fendo.2012.00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Spassov VZ, Luecke H, Gerwert K, Bashford D. pK(a) Calculations suggest storage of an excess proton in a hydrogenbonded water network in bacteriorhodopsin. J Mol Biol. 2001;312:203–219. doi: 10.1006/jmbi.2001.4902. [DOI] [PubMed] [Google Scholar]
  81. Standfuss J, Edwards PC, D’Antona A, Fransen M, Xie G, Oprian DD, Schertler GF. The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature. 2011;471:656–660. doi: 10.1038/nature09795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Stitham J, Arehart E, Gleim SR, Li N, Douville K, Hwa J. New insights into human prostacyclin receptor structure and function through natural and synthetic mutations of transmembrane charged residues. Br J Pharmacol. 2007;152:513–522. doi: 10.1038/sj.bjp.0707413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Strader CD, Sigal IS, Candelore MR, Rands E, Hill WS, Dixon RA. Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. J Biol Chem. 1988;263:10267–10271. [PubMed] [Google Scholar]
  84. Taddese B, Simpson LM, Wall ID, Blaney FE, Reynolds CA. Modeling active GPCR conformations. Methods Enzymol. 2013;522:21–35. doi: 10.1016/B978-0-12-407865-9.00002-9. [DOI] [PubMed] [Google Scholar]
  85. Thompson AA, Liu W, Chun E, Katritch V, Wu H, Vardy E, Huang XP, Trapella C, Guerrini R, Calo G, et al. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature. 2012;485:395–399. doi: 10.1038/nature11085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Tombola F, Pathak MM, Isacoff EY. How far will you go to sense voltage? Neuron. 2005;48:719–725. doi: 10.1016/j.neuron.2005.11.024. [DOI] [PubMed] [Google Scholar]
  87. Van Durme J, Horn F, Costagliola S, Vriend G, Vassart G. GRIS: glycoprotein-hormone receptor information system. Mol Endocrinol. 2006;20:2247–2255. doi: 10.1210/me.2006-0020. [DOI] [PubMed] [Google Scholar]
  88. Vanni S, Neri M, Tavernelli I, Rothlisberger U. A conserved protonation-induced switch can trigger “ionic-lock” formation in adrenergic receptors. J Mol Biol. 2010;397:1339–1349. doi: 10.1016/j.jmb.2010.01.060. [DOI] [PubMed] [Google Scholar]
  89. Venkatakrishnan AJ, Deupi X, Lebon G, Tate CG, Schertler GF, Babu MM. Molecular signatures of G-protein-coupled receptors. Nature. 2013;494:185–194. doi: 10.1038/nature11896. [DOI] [PubMed] [Google Scholar]
  90. Vogel R, Mahalingam M, Ludeke S, Huber T, Siebert F, Sakmar TP. Functional role of the “ionic lock”—an interhelical hydrogen-bond network in family A heptahelical receptors. J Mol Biol. 2008;380:648–655. doi: 10.1016/j.jmb.2008.05.022. [DOI] [PubMed] [Google Scholar]
  91. von Heijne G. Control of topology and mode of assembly of a polytopic membrane protein by positively charged residues. Nature. 1989;341:456–458. doi: 10.1038/341456a0. [DOI] [PubMed] [Google Scholar]
  92. Wacker D, Wang C, Katritch V, Han GW, Huang XP, Vardy E, McCorvy JD, Jiang Y, Chu M, Siu FY, et al. Structural features for functional selectivity at serotonin receptors. Science. 2013;340:615–619. doi: 10.1126/science.1232808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Wang C, Jiang Y, Ma J, Wu H, Wacker D, Katritch V, Han GW, Liu W, Huang XP, Vardy E, et al. Structural basis for molecular recognition at serotonin receptors. Science. 2013;340:610–614. doi: 10.1126/science.1232807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Warne T, Moukhametzianov R, Baker JG, Nehme R, Edwards PC, Leslie AG, Schertler GF, Tate CG. The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor. Nature. 2011;469:241–244. doi: 10.1038/nature09746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AG, Tate CG, Schertler GF. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature. 2008;454:486–491. doi: 10.1038/nature07101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. White JF, Noinaj N, Shibata Y, Love J, Kloss B, Xu F, Gvozdenovic-Jeremic J, Shah P, Shiloach J, Tate CG, et al. Structure of the agonist-bound neurotensin receptor. Nature. 2012;490:508–513. doi: 10.1038/nature11558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Wilson MH, Highfield HA, Limbird LE. The role of a conserved inter-transmembrane domain interface in regulating alpha(2a)-adrenergic receptor conformational stability and cell-surface turnover. Mol Pharmacol. 2001;59:929–938. doi: 10.1124/mol.59.4.929. [DOI] [PubMed] [Google Scholar]
  98. Wimley WC, Creamer TP, White SH. Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides. Biochemistry. 1996;35:5109–5124. doi: 10.1021/bi9600153. [DOI] [PubMed] [Google Scholar]
  99. Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC, et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science. 2010;330:1066–1071. doi: 10.1126/science.1194396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, et al. Structure of the human kappa-opioid receptor in complex with JDTic. Nature. 2012;485:327–332. doi: 10.1038/nature10939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Xu F, Wu H, Katritch V, Han GW, Jacobson KA, Gao ZG, Cherezov V, Stevens RC. Structure of an agonistbound human A2A adenosine receptor. Science. 2011;332:322–327. doi: 10.1126/science.1202793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Yanagawa M, Yamashita T, Shichida Y. Glutamate acts as a partial inverse agonist to metabotropic glutamate receptor with a single amino acid mutation in the transmembrane domain. J Biol Chem. 2013;288:9593–9601. doi: 10.1074/jbc.M112.437780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Zhang C, Srinivasan Y, Arlow DH, Fung JJ, Palmer D, Zheng Y, Green HF, Pandey A, Dror RO, Shaw DE, et al. Highresolution crystal structure of human protease-activated receptor 1. Nature. 2012;492:387–392. doi: 10.1038/nature11701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Zhou W, Flanagan C, Ballesteros JA, Konvicka K, Davidson JS, Weinstein H, Millar RP, Sealfon SC. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol Pharmacol. 1994;45:165–170. [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES